National Institute of Health (NIH) awards ResVita Bio an SBIR grant to develop RVB-001 as a treatment for Netherton Syndrome Leave a Comment / By Web & IT News Editor / September 20, 2022 The post National Institute of Health (NIH) awards ResVita Bio an SBIR grant to develop RVB-001 as a treatment for Netherton Syndrome first appeared on PressRelease.cc.
International News: Chinese Vocal Artist Luohai Wu Performs For U.N. Intangible Cultural HeritageMedia & Communications / By Web & IT News Editor
